title: Decision-making in polydrug amphetamine-type stimulant users: an fMRI study.
abstract: Qualitative poor decision-making and associated altered neuronal activation patterns have been described for the users of several drugs, amongst others for stimulants like amphetamine and MDMA. Deficits in decision-making might be caused by an augmented attraction to short-term rewarding properties despite negative long-term consequences, leading to rigid stimulus-response patterns. In the present imaging study, we investigated decision-making and associated neuronal activation in three groups differing in their exposure to amphetamine and MDMA. An established paradigm on risky choices was used to evaluate decision-making performance and corresponding functional magnet resonance imaging (fMRI) activation. Subjects could choose between a low-risk control gamble and an experimental gamble, which always differed in the probability of winning or losing, as well as the magnitudes of monetary gain or loss. Experienced users (EU), users with low exposure to stimulants and drug-naive controls, did not differ from each other in behavioral performance. In accordance with our hypotheses, the anticipation of reward led to an activation of primarily the frontal cortex and the striatum in low-exposure users and drug-naive controls. In contrast, frontal and parietal activation was observed in all groups when the actual outcome of an experimental gamble was presented. EU displayed more activation compared to both control groups when there was a high probability of winning. The study at hand supports the hypothesis that neuronal activation patterns might even differ between drug users and healthy controls when no behavioral deficits are apparent. In EU, the probability of the occurrence of an event has more influence on neuronal activation than on the actual magnitude of reinforcing properties of this event.
authors: Department of Psychiatry and Psychotherapy, University Hospital of Cologne, Cologne, Germany.
authors: Philip
authors: P
authors: Koester
authors: Kirsten G
authors: KG
authors: Volz
authors: Marc
authors: M
authors: Tittgemeyer
authors: Daniel
authors: D
authors: Wagner
authors: Benjamin
authors: B
authors: Becker
authors: Euphrosyne
authors: E
authors: Gouzoulis-Mayfrank
authors: Joerg
authors: J
authors: Daumann
mesh_terms: D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000008:administration & dosage*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D003657:Decision Making / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage*; D012201:Reward; D055815:Young Adult
chemical_list: D000662:Amphetamines; D000697:Central Nervous System Stimulants; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references: Brain Cogn. 2004 Jun;55(1):11-29
references: 15134840
references: Biol Psychiatry. 2008 Feb 1;63(3):256-62
references: 17719014
references: Neuroimage. 2010 Aug 15;52(2):429-35
references: 20417713
references: J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):610-4
references: 17088334
references: Trends Neurosci. 2006 Feb;29(2):116-24
references: 16406092
references: Neuroimage. 2001 Dec;14(6):1370-86
references: 11707093
references: Neuroimage. 2004;23 Suppl 1:S208-19
references: 15501092
references: Neuroimage. 2003 Jul;19(3):1085-94
references: 12880834
references: Psychopharmacology (Berl). 2005 Aug;180(4):607-11
references: 15372137
references: Neuroimage. 2011 Jan 15;54(2):794-801
references: 20817105
references: Science. 2004 Apr 9;304(5668):307-10
references: 15073380
references: Alcohol Clin Exp Res. 2012 Apr;36(4):604-15
references: 22250647
references: Psychopharmacology (Berl). 2013 Feb;225(4):923-34
references: 23001254
references: Hum Psychopharmacol. 2012 Mar;27(2):113-38
references: 22389076
references: Biol Psychiatry. 2004 Mar 15;55(6):594-602
references: 15013828
references: Neuroimage. 2005 Jun;26(2):480-92
references: 15907305
references: J Cereb Blood Flow Metab. 1992 Nov;12(6):900-18
references: 1400644
references: Eur Neuropsychopharmacol. 2010 Mar;20(3):153-63
references: 20061126
references: Hum Brain Mapp. 2002 Nov;17(3):143-55
references: 12391568
references: Med Image Anal. 2001 Jun;5(2):143-56
references: 11516708
references: Drug Alcohol Depend. 2003 Dec 11;72(3):225-35
references: 14643939
references: Neuropsychopharmacology. 1999 Apr;20(4):322-39
references: 10088133
references: Drug Alcohol Depend. 2008 Jul 1;96(1-2):99-110
references: 18384979
references: Addiction. 2013 Jan;108(1):136-45
references: 22831704
references: Neuropharmacology. 2009;56 Suppl 1:3-8
references: 18617195
references: J Drug Issues. 2009 Jan;39(1):115-132
references: 20622969
references: Brain. 2010 Jun;133(Pt 6):1779-97
references: 20483717
references: Brain. 2008 Nov;131(Pt 11):2936-45
references: 18842607
references: J Neurosci. 2001 Aug 15;21(16):RC159
references: 11459880
references: Neuroimage. 2002 Oct;17(2):825-41
references: 12377157
references: Neuropsychopharmacology. 2003 Jan;28(1):153-62
references: 12496952
references: Addict Behav. 2011 Dec;36(12):1337-40
references: 21849234
references: Eur J Neurosci. 2006 Sep;24(6):1744-50
references: 17004938
references: Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7185-90
references: 19369207
references: Biol Psychiatry. 2003 Jan 1;53(1):65-74
references: 12513946
references: Am J Drug Alcohol Abuse. 2007;33(6):777-89
references: 17994474
references: Psychopharmacology (Berl). 2005 Aug;180(4):612-23
references: 16163533
references: Front Neurosci. 2012 Apr 18;6:46
references: 22529770
references: Neuroscience. 2012 Sep 27;221:182-92
references: 22750208
references: Neuroimage. 2009 Nov 1;48(2):371-80
references: 19559801
references: Psychopharmacology (Berl). 2009 Apr;203(3):519-27
references: 19020868
references: Arch Gen Psychiatry. 2005 Jul;62(7):761-8
references: 15997017
references: Neuroimage. 2009 Mar;45(1 Suppl):S173-86
references: 19059349
references: Psychopharmacology (Berl). 2007 Jan;189(4):517-30
references: 16425060
references: Addiction. 2007 Apr;102 Suppl 1:33-43
references: 17493051
references: BMC Pharmacol. 2010 May 20;10:5
references: 20487539
references: Biol Psychiatry. 2011 May 1;69(9):867-74
references: 21272861
references: Psychopharmacology (Berl). 2009 Nov;207(1):73-83
references: 19680634
references: Am J Psychiatry. 2005 Aug;162(8):1403-13
references: 16055761
references: Biol Psychiatry. 2010 Dec 1;68(11):1061-5
references: 20875635